Literature DB >> 27340278

Whole-Exome Sequencing of Salivary Gland Mucoepidermoid Carcinoma.

Hyunseok Kang1, Marietta Tan2, Justin A Bishop3, Siân Jones4, Mark Sausen4, Patrick K Ha2, Nishant Agrawal5,6.   

Abstract

PURPOSE: Mucoepidermoid carcinoma (MEC) is the most common salivary gland malignancy. To explore the genetic origins of MEC, we performed systematic genomic analyses of these tumors. EXPERIMENTAL
DESIGN: Whole-exome sequencing and gene copy-number analyses were performed for 18 primary cancers with matched normal tissue. FISH was used to determine the presence or absence of the MECT1-MAML2 translocation in 17 tumors.
RESULTS: TP53 was the most commonly mutated gene in MEC (28%), and mutations were found only in intermediate- and high-grade tumors. Tumors with TP53 mutations had more mutations overall than tumors without TP53 mutations (P = 0.006). POU6F2 was the second most frequently mutated gene, found in three low-grade MECs with the same in-frame deletion. Somatic alterations in IRAK1, MAP3K9, ITGAL, ERBB4, OTOGL, KMT2C, and OBSCN were identified in at least two of the 18 tumors sequenced. FISH analysis confirmed the presence of the MECT1-MAML2 translocation in 15 of 17 tumors (88%).
CONCLUSIONS: Through these integrated genomic analyses, MECT1-MAML2 translocation and somatic TP53 and POU6F2 mutations appear to be the main drivers of MEC. Clin Cancer Res; 23(1); 283-8. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27340278      PMCID: PMC5182193          DOI: 10.1158/1078-0432.CCR-16-0720

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  44 in total

Review 1.  LFA-1 as a key regulator of immune function: approaches toward the development of LFA-1-based therapeutics.

Authors:  P A Giblin; R M Lemieux
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 2.  Histologic grading and prognostic biomarkers in salivary gland carcinomas.

Authors:  Raja R Seethala
Journal:  Adv Anat Pathol       Date:  2011-01       Impact factor: 3.875

3.  Genomic profiles and CRTC1-MAML2 fusion distinguish different subtypes of mucoepidermoid carcinoma.

Authors:  Kowan Ja Jee; Marta Persson; Kristiina Heikinheimo; Fabricio Passador-Santos; Katri Aro; Sakari Knuutila; Edward W Odell; Antti Mäkitie; Kaarina Sundelin; Göran Stenman; Ilmo Leivo
Journal:  Mod Pathol       Date:  2012-09-28       Impact factor: 7.842

4.  Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation.

Authors:  T Komiya; Y Park; S Modi; A B Coxon; H Oh; F J Kaye
Journal:  Oncogene       Date:  2006-05-01       Impact factor: 9.867

5.  Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes.

Authors:  Amy Coxon; Ester Rozenblum; Yoon-Soo Park; Nina Joshi; Junji Tsurutani; Phillip A Dennis; Ilan R Kirsch; Frederic J Kaye
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

6.  t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.

Authors:  Giovanni Tonon; Sanjay Modi; Lizi Wu; Akihito Kubo; Amy B Coxon; Takefumi Komiya; Kevin O'Neil; Kristen Stover; Adel El-Naggar; James D Griffin; Ilan R Kirsch; Frederic J Kaye
Journal:  Nat Genet       Date:  2003-01-21       Impact factor: 38.330

Review 7.  Molecular heterogeneity in mucoepidermoid carcinoma: conceptual and practical implications.

Authors:  Diana Bell; Adel K El-Naggar
Journal:  Head Neck Pathol       Date:  2013-03-05

Review 8.  A mucoepidermoid carcinoma of minor salivary gland with t(11;19)(q21;p13.1) as the only karyotypic abnormality.

Authors:  A K El-Naggar; M Lovell; A M Killary; G L Clayman; J G Batsakis
Journal:  Cancer Genet Cytogenet       Date:  1996-03

9.  Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria.

Authors:  Chetan Bettegowda; Long H Dang; Ross Abrams; David L Huso; Larry Dillehay; Ian Cheong; Nishant Agrawal; Scott Borzillary; J Michael McCaffery; E Latice Watson; Kuo-Shyan Lin; Fred Bunz; Kwamena Baidoo; Martin G Pomper; Kenneth W Kinzler; Bert Vogelstein; Shibin Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

10.  TP53 mutations in salivary gland neoplasms.

Authors:  Luciana Fasanella Matizonkas-Antonio; Ricardo Alves de Mesquita; Suzana C Orsini Machado de Souza; Fabio Daumas Nunes
Journal:  Braz Dent J       Date:  2005
View more
  25 in total

Review 1.  The Spectrum of Triple-Negative Breast Disease: High- and Low-Grade Lesions.

Authors:  Felipe C Geyer; Fresia Pareja; Britta Weigelt; Emad Rakha; Ian O Ellis; Stuart J Schnitt; Jorge S Reis-Filho
Journal:  Am J Pathol       Date:  2017-07-20       Impact factor: 4.307

2.  Mucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and Prognosis.

Authors:  Nicole A Cipriani; Jonathan J Lusardi; James McElherne; Alexander T Pearson; Andrea D Olivas; Carrie Fitzpatrick; Mark W Lingen; Elizabeth A Blair
Journal:  Am J Surg Pathol       Date:  2019-07       Impact factor: 6.394

Review 3.  p53 and Cell Fate: Sensitizing Head and Neck Cancer Stem Cells to Chemotherapy.

Authors:  Christie Rodriguez-Ramirez; Jacques E Nör
Journal:  Crit Rev Oncog       Date:  2018

4.  Salivary Gland Cancer in the Era of Routine Next-Generation Sequencing.

Authors:  Emilija Todorovic; Brendan C Dickson; Ilan Weinreb
Journal:  Head Neck Pathol       Date:  2020-03-02

5.  Immunohistochemical Assessment of BAP1 Protein in Mucoepidermoid Carcinomas.

Authors:  Aanchal Kakkar; Prerna Guleria; Karan Madan; Rajeev Kumar; Sunil Kumar; Deepali Jain
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-12-19

6.  Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9.

Authors:  Lu Liang; Wen-Yan Xu; Ao Shen; Hui-Yu Cen; Zhi-Jun Chen; Lin Tan; Ling-Min Zhang; Yu Zhang; Ji-Jun Fu; Ai-Ping Qin; Xue-Ping Lei; Song-Pei Li; Yu-Yan Qin; Jiong-Hua Huang; Xi-Yong Yu
Journal:  Acta Pharmacol Sin       Date:  2022-04-06       Impact factor: 6.150

7.  Genome-wide mutation profiling and related risk signature for prognosis of papillary renal cell carcinoma.

Authors:  Chuanjie Zhang; Yuxiao Zheng; Xiao Li; Xin Hu; Feng Qi; Jun Luo
Journal:  Ann Transl Med       Date:  2019-09

8.  Whole-Genome Sequencing of Common Salivary Gland Carcinomas: Subtype-Restricted and Shared Genetic Alterations.

Authors:  Tatiana V Karpinets; Yoshitsugu Mitani; Bin Liu; Jianhua Zhang; Kristen B Pytynia; Linton D Sellen; Danice T Karagiannis; Renata Ferrarotto; Andrew P Futreal; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2021-05-19       Impact factor: 12.531

9.  Synergistic efficacy of combined EGFR and HDAC inhibitors overcomes tolerance to EGFR monotherapy in salivary mucoepidermoid carcinoma.

Authors:  Kshitij Parag-Sharma; Jason Tasoulas; Adele M Musicant; Carlos H Viesi do Nascimento-Filho; Zhichuan Zhu; Chloe Twomey; Pengda Liu; Rogerio M Castilho; Antonio L Amelio
Journal:  Oral Oncol       Date:  2021-02-11       Impact factor: 5.337

10.  CRTC1/MAML2 directs a PGC-1α-IGF-1 circuit that confers vulnerability to PPARγ inhibition.

Authors:  Adele M Musicant; Kshitij Parag-Sharma; Weida Gong; Monideepa Sengupta; Arindam Chatterjee; Erin C Henry; Yi-Hsuan Tsai; Michele C Hayward; Siddharth Sheth; Renee Betancourt; Trevor G Hackman; Ricardo J Padilla; Joel S Parker; Jimena Giudice; Colin A Flaveny; David N Hayes; Antonio L Amelio
Journal:  Cell Rep       Date:  2021-02-23       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.